D G E Thiem1, R W Frick2, E Goetze2, M Gielisch2, B Al-Nawas2,3, P W Kämmerer2. 1. Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131, Mainz, Germany. daniel.thiem@unimedizin-mainz.de. 2. Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131, Mainz, Germany. 3. Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyung Hee University, Seoul, Korea.
Abstract
OBJECTIVES: In reconstructive surgery, flap monitoring is crucial for early identification of perfusion problems. Using hyperspectral imaging (HSI), this clinical study aimed to develop a non-invasive, objective approach for perfusion monitoring of free and pedicled flaps. MATERIAL AND METHODS: HSI of 22 free (FF) and 8 pedicled flaps (PF) in 30 patients was recorded over time. Parameters assessed were tissue oxygenation/superficial perfusion (0-1 mm) (StO2 (0-100%)), near-infrared perfusion/deep perfusion (0-4 mm) (NIR (0-100)), distribution of haemoglobin (THI (0-100)), and water (TWI (0-100)). Measurements up to 72 h were correlated to clinical assessment. RESULTS: Directly after flap inset, mean StO2 was significantly higher in FF (70.3 ± 13.6%) compared with PF 56.2 ± 14.2% (p = 0.05), whereas NIR, THI, and TWI were similar (NIR_p = 0.82, THI_p = 0.97, TWI_p = 0.27). After 24 h, StO2, NIR, THI, and TWI did not differ between FF and PF. After 48 h, StO2, NIR, and TWI did not differ between FF and PF whereas THI was significantly increased in FF compared with PF(p = 0.001). In three FF, perfusion decreased clinically and in HSI, 36(1), 40(2), 5(3), and 61(3) h after flap inset which was followed by prompt intervention. CONCLUSIONS: StO2 < 40%, NIR < 25/100, and THI < 40/100 indicated arterial occlusion, whereas venous problems revealed an increase of THI. In comparison with FF, perfusion parameters of PF were decreased after flap transfer but remained similar to FF later on. CLINICAL RELEVANCE: HSI provides objective and non-invasive perfusion monitoring after flap transplantation in accordance to the clinical situation. With HSI, signs of deterioration can be detected hours before clinical diagnosis.
OBJECTIVES: In reconstructive surgery, flap monitoring is crucial for early identification of perfusion problems. Using hyperspectral imaging (HSI), this clinical study aimed to develop a non-invasive, objective approach for perfusion monitoring of free and pedicled flaps. MATERIAL AND METHODS: HSI of 22 free (FF) and 8 pedicled flaps (PF) in 30 patients was recorded over time. Parameters assessed were tissue oxygenation/superficial perfusion (0-1 mm) (StO2 (0-100%)), near-infrared perfusion/deep perfusion (0-4 mm) (NIR (0-100)), distribution of haemoglobin (THI (0-100)), and water (TWI (0-100)). Measurements up to 72 h were correlated to clinical assessment. RESULTS: Directly after flap inset, mean StO2 was significantly higher in FF (70.3 ± 13.6%) compared with PF 56.2 ± 14.2% (p = 0.05), whereas NIR, THI, and TWI were similar (NIR_p = 0.82, THI_p = 0.97, TWI_p = 0.27). After 24 h, StO2, NIR, THI, and TWI did not differ between FF and PF. After 48 h, StO2, NIR, and TWI did not differ between FF and PF whereas THI was significantly increased in FF compared with PF(p = 0.001). In three FF, perfusion decreased clinically and in HSI, 36(1), 40(2), 5(3), and 61(3) h after flap inset which was followed by prompt intervention. CONCLUSIONS:StO2 < 40%, NIR < 25/100, and THI < 40/100 indicated arterial occlusion, whereas venous problems revealed an increase of THI. In comparison with FF, perfusion parameters of PF were decreased after flap transfer but remained similar to FF later on. CLINICAL RELEVANCE: HSI provides objective and non-invasive perfusion monitoring after flap transplantation in accordance to the clinical situation. With HSI, signs of deterioration can be detected hours before clinical diagnosis.
Authors: Eberhard Grambow; Niels Arne Sandkühler; Justus Groß; Daniel G E Thiem; Michael Dau; Matthias Leuchter; Malte Weinrich Journal: J Clin Med Date: 2022-01-30 Impact factor: 4.241
Authors: Michael Knitschke; Anna Katrin Baumgart; Christina Bäcker; Christian Adelung; Fritz Roller; Daniel Schmermund; Sebastian Böttger; Philipp Streckbein; Hans-Peter Howaldt; Sameh Attia Journal: Front Oncol Date: 2022-01-19 Impact factor: 6.244
Authors: Daniel G E Thiem; Fabia Siegberg; Paul Römer; Sebastian Blatt; Andreas Pabst; Diana Heimes; Bilal Al-Nawas; Peer W Kämmerer Journal: J Clin Med Date: 2022-06-22 Impact factor: 4.964
Authors: Philipp Becker; Sebastian Blatt; Andreas Pabst; Diana Heimes; Bilal Al-Nawas; Peer W Kämmerer; Daniel G E Thiem Journal: J Clin Med Date: 2022-07-16 Impact factor: 4.964
Authors: Peer W Kämmerer; Vivien Engel; Franz Plocksties; Anika Jonitz-Heincke; Dirk Timmermann; Nadja Engel; Bernhard Frerich; Rainer Bader; Daniel G E Thiem; Anna Skorska; Robert David; Bilal Al-Nawas; Michael Dau Journal: Biomedicines Date: 2020-11-08
Authors: Tim Pruimboom; Anouk A M A Lindelauf; Eric Felli; John H Sawor; An E K Deliaert; René R W J van der Hulst; Mahdi Al-Taher; Michele Diana; Rutger M Schols Journal: Diagnostics (Basel) Date: 2022-01-13
Authors: Anouk A M A Lindelauf; Alexander G Saelmans; Sander M J van Kuijk; René R W J van der Hulst; Rutger M Schols Journal: Life (Basel) Date: 2022-01-03
Authors: Maximilian Dietrich; Berkin Özdemir; Daniel Gruneberg; Clara Petersen; Alexander Studier-Fischer; Maik von der Forst; Felix C F Schmitt; Mascha O Fiedler; Felix Nickel; Beat Peter Müller-Stich; Thorsten Brenner; Markus A Weigand; Florian Uhle; Karsten Schmidt Journal: Biomedicines Date: 2021-12-03